Brief: Amylyx Pharmaceuticals Expects To Incur Severance-Related Charges Of About $19 Million

Amylyx Pharmaceuticals

04/04/2024 12:20

April 4 (Reuters) - Amylyx Pharmaceuticals Inc  AMLX.O :
    * AMYLYX PHARMACEUTICALS - AS PART OF RESTRUCTURING PLAN,
COMPANY
EXPECTS TO INCUR SEVERANCE AND SEVERANCE-RELATED CHARGES OF
APPROXIMATELY $19 MILLION
    * AMYLYX PHARMACEUTICALS INC - EXPECTS TO SUBSTANTIALLY
COMPLETE
RESTRUCTURING PLAN BY END OF Q3 OF 2024
    * AMYLYX PHARMACEUTICALS INC: ALSO EVALUATING ITS INVENTORY
PURCHASE COMMITMENTS AND IMPACT ITS RESTRUCTURING PLAN WILL HAVE
ON INVENTORY OBSOLESCENCE

Source text for Eikon:  ID:n0001193125-24-086609 
Further company coverage:  AMLX.O 

 ((Reuters.Briefs@thomsonreuters.com;))